NCT06587087View on ClinicalTrials.gov

A Proof of Concept (PoC), Randomized, Controlled Study to Validate the Algorithm and Evaluate the Accuracy, Safety and Pain Level of the Smartest-AE in Comparison to Self-measure Blood Glucose Levels

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

February 15, 2025

Conditions
Diabetes MellitusGestational Diabetes Mellitus (GDM)Pre Diabetes
Interventions
DEVICE

Smartest-AE: The lancet that will be used will be the Vitrex Soft Lite lll 28G.

The lancet that will be used for all subjects will be the Vitrex Soft Lite lll 28G.

Trial Locations (1)

15208

The BARUCH PADEH Medical Center, Poriya, Poria – Neve Oved

Sponsors
All Listed Sponsors
collaborator

Israel Innovation Authority

UNKNOWN

lead

Smartest Technologies

INDUSTRY

NCT06587087 - A Proof of Concept (PoC), Randomized, Controlled Study to Validate the Algorithm and Evaluate the Accuracy, Safety and Pain Level of the Smartest-AE in Comparison to Self-measure Blood Glucose Levels | Biotech Hunter | Biotech Hunter